VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,094,386 | -41.6% | 136,531 | -9.4% | 0.00% | – |
| Q2 2023 | $3,583,940 | +41.9% | 150,649 | +51.8% | 0.00% | – |
| Q1 2023 | $2,525,047 | -93.0% | 99,255 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $35,838,274 | +21.8% | 1,226,918 | -14.5% | 0.01% | +33.3% |
| Q3 2022 | $29,416,000 | +148.0% | 1,434,212 | +39.9% | 0.01% | +100.0% |
| Q2 2022 | $11,859,000 | -31.9% | 1,024,999 | +8.9% | 0.00% | -25.0% |
| Q1 2022 | $17,403,000 | -6.7% | 941,218 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $18,650,000 | +42286.4% | 943,340 | +94.1% | 0.00% | – |
| Q1 2021 | $44,000 | – | 485,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |